Free Trial

Ambev (ABEV) Stock Forecast & Price Target

Ambev logo
$2.36 +0.02 (+0.85%)
Closing price 04/2/2025 03:58 PM Eastern
Extended Trading
$2.35 -0.01 (-0.25%)
As of 05:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ambev - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
1

Based on 4 Wall Street analysts who have issued ratings for Ambev in the last 12 months, the stock has a consensus rating of "Hold." Out of the 4 analysts, 3 have given a hold rating, and 1 has given a buy rating for ABEV.

Consensus Price Target

$2.45
3.81% Upside
According to the 4 analysts' twelve-month price targets for Ambev, the average price target is $2.45. The highest price target for ABEV is $2.90, while the lowest price target for ABEV is $2.00. The average price target represents a forecasted upside of 3.81% from the current price of $2.36.
Get the Latest News and Ratings for ABEV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ambev and its competitors.

Sign Up

ABEV Analyst Ratings Over Time

TypeCurrent Forecast
4/3/24 to 4/3/25
1 Month Ago
3/4/24 to 3/4/25
3 Months Ago
1/4/24 to 1/3/25
1 Year Ago
4/4/23 to 4/3/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
3 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.45$2.45$2.70$3.20
Forecasted Upside3.81% Upside16.95% Upside52.54% Upside30.35% Upside
Consensus Rating
Hold
Hold
Hold
Hold
Remove Ads

ABEV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ABEV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Ambev Stock vs. The Competition

TypeAmbevConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.25
2.51
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside3.81% Upside61.87% Upside17.78% Upside
News Sentiment Rating
Positive News

See Recent ABEV News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/22/2025Citigroup
3 of 5 stars
Renata Cabral
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
1/21/2025Barclays
3 of 5 stars
Benjamin Theurer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$2.50 ➝ $2.00+12.04%
1/17/2025Bank of America
3 of 5 stars
 DowngradeBuy ➝ Neutral
7/31/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$3.20 ➝ $2.90+40.78%
3/1/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Neutral
12/8/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight
11/22/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$2.86+4.57%
5/24/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$3.74+29.86%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:57 AM ET.


Should I Buy Ambev Stock? ABEV Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, March 29, 2025. Please send any questions or comments about these Ambev pros and cons to contact@marketbeat.com.

Ambev
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Ambev S.A.:

  • Foresight Global Investors Inc. recently increased its holdings in Ambev S.A. by 41.1%, indicating strong institutional interest and confidence in the company's future performance.
  • GQG Partners LLC also raised its stake by 51.9%, showcasing significant investment from reputable funds, which can be a positive signal for potential investors.
  • The current stock price of Ambev S.A. is $2.36, which may present a buying opportunity for investors looking for value in the beverage sector.
  • Analysts have a consensus rating of "Hold" with a target price of $2.45, suggesting that there is potential for price appreciation in the near term.
  • Ambev S.A. has a low debt-to-equity ratio of 0.02, indicating a strong balance sheet and financial stability, which can be attractive for risk-averse investors.

Ambev
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Ambev S.A. for these reasons:

  • Barclays recently downgraded its price objective for Ambev S.A. from $2.50 to $2.00, reflecting a more cautious outlook on the stock's performance.
  • Bank of America has lowered its rating from "buy" to "neutral," indicating a potential slowdown in growth expectations for the company.
  • Despite recent institutional investments, only 8.13% of the stock is owned by institutional investors and hedge funds, suggesting limited institutional confidence compared to other companies.
  • The stock has experienced fluctuations, trading down 1.5% recently, which may indicate volatility and uncertainty in the market.
  • Ambev S.A. has a price-to-earnings (P/E) ratio of 12.64, which, while not excessively high, may suggest that the stock is not undervalued compared to its earnings potential.

ABEV Forecast - Frequently Asked Questions

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Ambev is $2.45, with a high forecast of $2.90 and a low forecast of $2.00.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ambev in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ABEV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABEV, but not buy additional shares or sell existing shares.

According to analysts, Ambev's stock has a predicted upside of 3.81% based on their 12-month stock forecasts.

Over the previous 90 days, Ambev's stock had 1 downgrade by analysts.

Ambev has been rated by research analysts at Bank of America, Barclays, and Citigroup in the past 90 days.

Analysts like Ambev less than other "consumer staples" companies. The consensus rating for Ambev is Hold while the average consensus rating for "consumer staples" companies is Moderate Buy. Learn more on how ABEV compares to other companies.


This page (NYSE:ABEV) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners